People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elute, Inc. | — | Pharmaceuticals | Seed | $1.6M | $62.2M | 2016 |
Kirk P. Andriano at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kirk P. Andriano on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cheryl R. Blanchard | 1 | 4 |
| Dennis B. Farrar | 1 | 2 |
| ASHOK C. KHANDKAR | 1 | 2 |
| Stephanie L. Sorensen | 1 | 1 |
| Daniel P. Liston | 1 | 1 |
| Kristofer D. Sinclair | 1 | 1 |
| Philip A. Davidson | 1 | 1 |
| David W. Grainger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.